drugset / Trial / NCT01230463

Study of Whether 15 mg Dose of Ketorolac IV is as Effective as a 30 mg Dose.

NCT01230463

Unknown 50 enrolled University of Calgary
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary aim of this study is to show the non-inferiority of 15 mg intraoperative dose of ketorolac as compared to the standard 30 mg ketorolac by looking at the VAS scores 4 hours after an adult spine surgery.

Timeline

Start
2010-09
Primary completion
2011-09
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketorolac Tromethamine Small molecule 15 mg Intravenous
Comparator Ketorolac Tromethamine Small molecule 30 mg Intravenous

Indications

No indication recorded.